HHS Finalizes Rule on 340B Administrative Dispute Resolution Process

Originally published by our sister publication Specialty Pharmacy Continuum

Covered entities (CEs) and manufacturers in the federal 340B Drug Pricing Program now have a new process for resolving disputes regarding overcharging, duplicate discounts or diversion, thanks to a new rule issued on Friday, April 19, by the Health Resources and Services Administration (HRSA).